VERV — Verve Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Verve Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	72.1	360	555	624	524
Net Total Receivables	—	—	1.01	5.9	3.25
Prepaid Expenses
Total Current Assets	74	367	563	638	543
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.98	9.06	111	108	96.7
Other Long Term Assets
Total Assets	78.4	384	679	753	647
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	7.32	22	35.1	37	42.9
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.2	26.8	128	153	154
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	61.3	357	551	600	493
Total Liabilities & Shareholders' Equity	78.4	384	679	753	647
Total Common Shares Outstanding